Emerald Investment Advisers LLC Invests $11.57 Million in Danaher Corporation $DHR

Emerald Investment Advisers LLC purchased a new stake in Danaher Corporation (NYSE:DHRFree Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 16,065 shares of the conglomerate’s stock, valued at approximately $11,567,000. Danaher makes up approximately 0.8% of Emerald Investment Advisers LLC’s investment portfolio, making the stock its 29th largest holding.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Meeder Asset Management Inc. bought a new stake in shares of Danaher during the second quarter worth $44,000. MidFirst Bank bought a new position in shares of Danaher in the 2nd quarter valued at $46,000. Bell Investment Advisors Inc acquired a new stake in shares of Danaher during the 2nd quarter valued at $47,000. State of Wyoming bought a new stake in Danaher during the 2nd quarter worth $74,000. Finally, Hilton Head Capital Partners LLC bought a new stake in Danaher during the 4th quarter worth $27,000. 79.05% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have commented on DHR. Evercore reiterated an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research report on Monday, July 6th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. DZ Bank assumed coverage on Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. Argus cut their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Finally, Citigroup assumed coverage on shares of Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $228.91.

Get Our Latest Research Report on Danaher

Danaher Stock Up 1.6%

Shares of DHR opened at $219.42 on Friday. The company has a market capitalization of $154.25 billion, a PE ratio of 38.97, a PEG ratio of 2.69 and a beta of 0.78. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The stock’s 50-day moving average price is $195.80 and its two-hundred day moving average price is $192.61. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter in the prior year, the firm posted $0.77 earnings per share. The business’s quarterly revenue was up 5.5% on a year-over-year basis. On average, analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.